Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	134.13	143.74	151.79	280.12	447.65	41.95
Short-Term Investments	554.29	606.35	847.12	677.95	230.42	313.86
Cash & Short-Term Investments	688.42	750.09	998.92	958.07	678.06	355.82
Cash Growth	-21.01%	-24.91%	4.26%	41.30%	90.57%	-15.58%
Receivables	-	-	5.22	4.94	82.65	-
Prepaid Expenses	10.12	16.7	12.11	11.47	9.39	4.72
Other Current Assets	5.73	3.32	3.26	1.76	-	-
Total Current Assets	704.27	770.1	1,020	976.24	770.1	360.54
Property, Plant & Equipment	63.27	68.87	75.39	27.32	28.83	31.65
Other Intangible Assets	2.3	2.3	2.3	2.3	-	-
Other Long-Term Assets	2.71	2.71	2.58	2.58	0.9	0.88
Total Assets	772.55	843.98	1,100	1,008	799.83	393.07
Accounts Payable	11.17	9.21	10.58	8.28	6.35	6.99
Accrued Expenses	27.77	14.89	22.7	13.56	5.56	3.41
Current Portion of Leases	5.34	4.96	4.28	1.84	1.52	1.25
Current Unearned Revenue	-	-	-	0.25	-	-
Other Current Liabilities	0.77	1.2	26.15	0.4	0.2	0.33
Total Current Liabilities	45.04	30.27	63.71	24.32	13.63	11.99
Long-Term Leases	45.76	48.5	53.47	21.06	22.9	23.58
Other Long-Term Liabilities	-	13.21	32.38	65.26	0	0.16
Total Liabilities	90.81	91.98	149.55	110.64	36.54	35.73
Common Stock	0.13	0.13	0.12	0.11	0.09	0
Additional Paid-In Capital	2,257	2,153	2,019	1,667	1,167	8.72
Retained Earnings	-1,574	-1,401	-1,059	-768.1	-404.23	-189.48
Comprehensive Income & Other	-1.34	-0.2	-10.42	-1.09	0.06	0.33
Total Common Equity	681.74	752	950.22	897.81	763.29	-180.44
Shareholders' Equity	681.74	752	950.22	897.81	763.29	357.34
Total Liabilities & Equity	772.55	843.98	1,100	1,008	799.83	393.07
Total Debt	51.1	53.47	57.74	22.9	24.42	24.83
Net Cash (Debt)	637.32	696.62	941.18	935.17	653.64	330.98
Net Cash Growth	-21.88%	-25.98%	0.64%	43.07%	97.48%	-21.44%
Net Cash Per Share	4.99	5.68	8.39	9.83	15.34	95.92
Filing Date Shares Outstanding	133.89	131.18	121.38	108.28	90.32	86.59
Total Common Shares Outstanding	133.32	127.46	121.11	108.21	89.91	4.04
Working Capital	659.23	739.83	955.8	951.92	756.47	348.55
Book Value Per Share	5.11	5.90	7.85	8.30	8.49	-44.69
Tangible Book Value	679.44	749.7	947.92	895.51	763.29	-180.44
Tangible Book Value Per Share	5.10	5.88	7.83	8.28	8.49	-44.69
Machinery	-	29.08	24.98	17.88	15.32	13.73
Construction In Progress	-	1.58	1.22	0.13	0.58	0.49
Leasehold Improvements	-	3.83	3.83	2.9	0.89	0.86

Source: S&P Capital IQ. Standard template. Financial Sources.